- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Opioid Use Disorder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Opioid Use Disorder market size is estimated to be worth US$ 1798.3 million in 2021 and is forecast to a readjusted size of USD 2608.2 million by 2028 with a CAGR of 5.5% during review period. Moderate Pain Treatment accounting for % of the Opioid Use Disorder global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Buprenorphine segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Opioid Use Disorder include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, and Teva Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Opioid Use Disorder market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Buprenorphine
Methadone
Naltrexone
Market segment by Application, can be divided into
Moderate Pain Treatment
Severe Pain Treatment
Market segment by players, this report covers
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Opioid Use Disorder product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Opioid Use Disorder, with revenue, gross margin and global market share of Opioid Use Disorder from 2019 to 2022.
Chapter 3, the Opioid Use Disorder competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Opioid Use Disorder market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Opioid Use Disorder research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Opioid Use Disorder
1.2 Classification of Opioid Use Disorder by Type
1.2.1 Overview: Global Opioid Use Disorder Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Opioid Use Disorder Revenue Market Share by Type in 2021
1.2.3 Buprenorphine
1.2.4 Methadone
1.2.5 Naltrexone
1.3 Global Opioid Use Disorder Market by Application
1.3.1 Overview: Global Opioid Use Disorder Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Moderate Pain Treatment
1.3.3 Severe Pain Treatment
1.4 Global Opioid Use Disorder Market Size & Forecast
1.5 Global Opioid Use Disorder Market Size and Forecast by Region
1.5.1 Global Opioid Use Disorder Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Opioid Use Disorder Market Size by Region, (2017-2022)
1.5.3 North America Opioid Use Disorder Market Size and Prospect (2017-2028)
1.5.4 Europe Opioid Use Disorder Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Opioid Use Disorder Market Size and Prospect (2017-2028)
1.5.6 South America Opioid Use Disorder Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Opioid Use Disorder Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioid Use Disorder Market Drivers
1.6.2 Opioid Use Disorder Market Restraints
1.6.3 Opioid Use Disorder Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Indivior
2.1.1 Indivior Details
2.1.2 Indivior Major Business
2.1.3 Indivior Opioid Use Disorder Product and Solutions
2.1.4 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Indivior Recent Developments and Future Plans
2.2 Alkermes
2.2.1 Alkermes Details
2.2.2 Alkermes Major Business
2.2.3 Alkermes Opioid Use Disorder Product and Solutions
2.2.4 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Alkermes Recent Developments and Future Plans
2.3 Titan Pharmaceuticals
2.3.1 Titan Pharmaceuticals Details
2.3.2 Titan Pharmaceuticals Major Business
2.3.3 Titan Pharmaceuticals Opioid Use Disorder Product and Solutions
2.3.4 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Titan Pharmaceuticals Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals
2.4.1 Hikma Pharmaceuticals Details
2.4.2 Hikma Pharmaceuticals Major Business
2.4.3 Hikma Pharmaceuticals Opioid Use Disorder Product and Solutions
2.4.4 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.5 Teva Pharmaceuticals
2.5.1 Teva Pharmaceuticals Details
2.5.2 Teva Pharmaceuticals Major Business
2.5.3 Teva Pharmaceuticals Opioid Use Disorder Product and Solutions
2.5.4 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.6 MediciNova
2.6.1 MediciNova Details
2.6.2 MediciNova Major Business
2.6.3 MediciNova Opioid Use Disorder Product and Solutions
2.6.4 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 MediciNova Recent Developments and Future Plans
2.7 Orexo
2.7.1 Orexo Details
2.7.2 Orexo Major Business
2.7.3 Orexo Opioid Use Disorder Product and Solutions
2.7.4 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Orexo Recent Developments and Future Plans
2.8 Camurus
2.8.1 Camurus Details
2.8.2 Camurus Major Business
2.8.3 Camurus Opioid Use Disorder Product and Solutions
2.8.4 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Camurus Recent Developments and Future Plans
2.9 Omeros
2.9.1 Omeros Details
2.9.2 Omeros Major Business
2.9.3 Omeros Opioid Use Disorder Product and Solutions
2.9.4 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Omeros Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Opioid Use Disorder Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Opioid Use Disorder Players Market Share in 2021
3.2.2 Top 10 Opioid Use Disorder Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Opioid Use Disorder Players Head Office, Products and Services Provided
3.4 Opioid Use Disorder Mergers & Acquisitions
3.5 Opioid Use Disorder New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Opioid Use Disorder Revenue and Market Share by Type (2017-2022)
4.2 Global Opioid Use Disorder Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Opioid Use Disorder Revenue Market Share by Application (2017-2022)
5.2 Global Opioid Use Disorder Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Opioid Use Disorder Revenue by Type (2017-2028)
6.2 North America Opioid Use Disorder Revenue by Application (2017-2028)
6.3 North America Opioid Use Disorder Market Size by Country
6.3.1 North America Opioid Use Disorder Revenue by Country (2017-2028)
6.3.2 United States Opioid Use Disorder Market Size and Forecast (2017-2028)
6.3.3 Canada Opioid Use Disorder Market Size and Forecast (2017-2028)
6.3.4 Mexico Opioid Use Disorder Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Opioid Use Disorder Revenue by Type (2017-2028)
7.2 Europe Opioid Use Disorder Revenue by Application (2017-2028)
7.3 Europe Opioid Use Disorder Market Size by Country
7.3.1 Europe Opioid Use Disorder Revenue by Country (2017-2028)
7.3.2 Germany Opioid Use Disorder Market Size and Forecast (2017-2028)
7.3.3 France Opioid Use Disorder Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Opioid Use Disorder Market Size and Forecast (2017-2028)
7.3.5 Russia Opioid Use Disorder Market Size and Forecast (2017-2028)
7.3.6 Italy Opioid Use Disorder Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Opioid Use Disorder Revenue by Type (2017-2028)
8.2 Asia-Pacific Opioid Use Disorder Revenue by Application (2017-2028)
8.3 Asia-Pacific Opioid Use Disorder Market Size by Region
8.3.1 Asia-Pacific Opioid Use Disorder Revenue by Region (2017-2028)
8.3.2 China Opioid Use Disorder Market Size and Forecast (2017-2028)
8.3.3 Japan Opioid Use Disorder Market Size and Forecast (2017-2028)
8.3.4 South Korea Opioid Use Disorder Market Size and Forecast (2017-2028)
8.3.5 India Opioid Use Disorder Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Opioid Use Disorder Market Size and Forecast (2017-2028)
8.3.7 Australia Opioid Use Disorder Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Opioid Use Disorder Revenue by Type (2017-2028)
9.2 South America Opioid Use Disorder Revenue by Application (2017-2028)
9.3 South America Opioid Use Disorder Market Size by Country
9.3.1 South America Opioid Use Disorder Revenue by Country (2017-2028)
9.3.2 Brazil Opioid Use Disorder Market Size and Forecast (2017-2028)
9.3.3 Argentina Opioid Use Disorder Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Opioid Use Disorder Revenue by Type (2017-2028)
10.2 Middle East & Africa Opioid Use Disorder Revenue by Application (2017-2028)
10.3 Middle East & Africa Opioid Use Disorder Market Size by Country
10.3.1 Middle East & Africa Opioid Use Disorder Revenue by Country (2017-2028)
10.3.2 Turkey Opioid Use Disorder Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Opioid Use Disorder Market Size and Forecast (2017-2028)
10.3.4 UAE Opioid Use Disorder Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Opioid Use Disorder Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Opioid Use Disorder Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Opioid Use Disorder Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Opioid Use Disorder Revenue (USD Million) by Region (2017-2022)
Table 5. Global Opioid Use Disorder Revenue Market Share by Region (2023-2028)
Table 6. Indivior Corporate Information, Head Office, and Major Competitors
Table 7. Indivior Major Business
Table 8. Indivior Opioid Use Disorder Product and Solutions
Table 9. Indivior Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Alkermes Corporate Information, Head Office, and Major Competitors
Table 11. Alkermes Major Business
Table 12. Alkermes Opioid Use Disorder Product and Solutions
Table 13. Alkermes Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Titan Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 15. Titan Pharmaceuticals Major Business
Table 16. Titan Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 17. Titan Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Hikma Pharmaceuticals Major Business
Table 20. Hikma Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 21. Hikma Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Teva Pharmaceuticals Major Business
Table 24. Teva Pharmaceuticals Opioid Use Disorder Product and Solutions
Table 25. Teva Pharmaceuticals Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. MediciNova Corporate Information, Head Office, and Major Competitors
Table 27. MediciNova Major Business
Table 28. MediciNova Opioid Use Disorder Product and Solutions
Table 29. MediciNova Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Orexo Corporate Information, Head Office, and Major Competitors
Table 31. Orexo Major Business
Table 32. Orexo Opioid Use Disorder Product and Solutions
Table 33. Orexo Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Camurus Corporate Information, Head Office, and Major Competitors
Table 35. Camurus Major Business
Table 36. Camurus Opioid Use Disorder Product and Solutions
Table 37. Camurus Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Omeros Corporate Information, Head Office, and Major Competitors
Table 39. Omeros Major Business
Table 40. Omeros Opioid Use Disorder Product and Solutions
Table 41. Omeros Opioid Use Disorder Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Opioid Use Disorder Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Opioid Use Disorder Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Opioid Use Disorder by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Opioid Use Disorder Players Head Office, Products and Services Provided
Table 46. Opioid Use Disorder Mergers & Acquisitions in the Past Five Years
Table 47. Opioid Use Disorder New Entrants and Expansion Plans
Table 48. Global Opioid Use Disorder Revenue (USD Million) by Type (2017-2022)
Table 49. Global Opioid Use Disorder Revenue Share by Type (2017-2022)
Table 50. Global Opioid Use Disorder Revenue Forecast by Type (2023-2028)
Table 51. Global Opioid Use Disorder Revenue by Application (2017-2022)
Table 52. Global Opioid Use Disorder Revenue Forecast by Application (2023-2028)
Table 53. North America Opioid Use Disorder Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Opioid Use Disorder Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Opioid Use Disorder Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Opioid Use Disorder Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Opioid Use Disorder Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Opioid Use Disorder Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Opioid Use Disorder Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Opioid Use Disorder Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Opioid Use Disorder Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Opioid Use Disorder Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Opioid Use Disorder Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Opioid Use Disorder Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Opioid Use Disorder Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Opioid Use Disorder Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Opioid Use Disorder Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Opioid Use Disorder Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Opioid Use Disorder Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Opioid Use Disorder Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Opioid Use Disorder Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Opioid Use Disorder Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Opioid Use Disorder Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Opioid Use Disorder Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Opioid Use Disorder Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Opioid Use Disorder Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Opioid Use Disorder Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Opioid Use Disorder Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Opioid Use Disorder Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Opioid Use Disorder Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Opioid Use Disorder Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Opioid Use Disorder Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Opioid Use Disorder Picture
Figure 2. Global Opioid Use Disorder Revenue Market Share by Type in 2021
Figure 3. Buprenorphine
Figure 4. Methadone
Figure 5. Naltrexone
Figure 6. Opioid Use Disorder Revenue Market Share by Application in 2021
Figure 7. Moderate Pain Treatment Picture
Figure 8. Severe Pain Treatment Picture
Figure 9. Global Opioid Use Disorder Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Opioid Use Disorder Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Opioid Use Disorder Revenue Market Share by Region (2017-2028)
Figure 12. Global Opioid Use Disorder Revenue Market Share by Region in 2021
Figure 13. North America Opioid Use Disorder Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Opioid Use Disorder Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Opioid Use Disorder Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Opioid Use Disorder Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Opioid Use Disorder Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Opioid Use Disorder Market Drivers
Figure 19. Opioid Use Disorder Market Restraints
Figure 20. Opioid Use Disorder Market Trends
Figure 21. Indivior Recent Developments and Future Plans
Figure 22. Alkermes Recent Developments and Future Plans
Figure 23. Titan Pharmaceuticals Recent Developments and Future Plans
Figure 24. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 25. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 26. MediciNova Recent Developments and Future Plans
Figure 27. Orexo Recent Developments and Future Plans
Figure 28. Camurus Recent Developments and Future Plans
Figure 29. Omeros Recent Developments and Future Plans
Figure 30. Global Opioid Use Disorder Revenue Share by Players in 2021
Figure 31. Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Opioid Use Disorder Revenue Market Share in 2021
Figure 33. Global Top 10 Players Opioid Use Disorder Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Opioid Use Disorder Revenue Share by Type in 2021
Figure 36. Global Opioid Use Disorder Market Share Forecast by Type (2023-2028)
Figure 37. Global Opioid Use Disorder Revenue Share by Application in 2021
Figure 38. Global Opioid Use Disorder Market Share Forecast by Application (2023-2028)
Figure 39. North America Opioid Use Disorder Sales Market Share by Type (2017-2028)
Figure 40. North America Opioid Use Disorder Sales Market Share by Application (2017-2028)
Figure 41. North America Opioid Use Disorder Revenue Market Share by Country (2017-2028)
Figure 42. United States Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Opioid Use Disorder Sales Market Share by Type (2017-2028)
Figure 46. Europe Opioid Use Disorder Sales Market Share by Application (2017-2028)
Figure 47. Europe Opioid Use Disorder Revenue Market Share by Country (2017-2028)
Figure 48. Germany Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Opioid Use Disorder Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Opioid Use Disorder Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Opioid Use Disorder Revenue Market Share by Region (2017-2028)
Figure 56. China Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Opioid Use Disorder Sales Market Share by Type (2017-2028)
Figure 63. South America Opioid Use Disorder Sales Market Share by Application (2017-2028)
Figure 64. South America Opioid Use Disorder Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Opioid Use Disorder Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Opioid Use Disorder Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Opioid Use Disorder Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Opioid Use Disorder Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
